Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$5.27 - $6.9 $1.84 Million - $2.41 Million
-349,068 Reduced 69.68%
151,907 $1.03 Million
Q1 2023

May 12, 2023

BUY
$3.14 - $6.19 $1.19 Million - $2.35 Million
379,924 Added 313.85%
500,975 $3.1 Million
Q4 2022

Feb 13, 2023

SELL
$3.73 - $4.6 $2.69 Million - $3.32 Million
-721,006 Reduced 85.62%
121,051 $451,000
Q3 2022

Nov 10, 2022

BUY
$3.48 - $4.98 $1.55 Million - $2.21 Million
444,280 Added 111.69%
842,057 $3.6 Million
Q2 2022

Aug 12, 2022

BUY
$3.42 - $10.06 $1.36 Million - $4 Million
397,777 New
397,777 $1.5 Million

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $39.5M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Cohanzick Management, LLC Portfolio

Follow Cohanzick Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohanzick Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cohanzick Management, LLC with notifications on news.